Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
Zimmer Trabecular Metal Total Ankle PMCF
NCT02038140 · View on ClinicalTrials.gov ↗
Study Summary
The primary objective of this study is to obtain implant survivorship and clinical outcome data for commercially available Zimmer Trabecular Metal Total Ankle implants used in primary or revision total ankle arthroplasty. The assessment will include implant survivorship and clinical performance measured by pain and function, quality of life data, radiographic parameters and survivorship.
Conditions Studied
Interventions
- DEVICE Zimmer Trabecular Metal Total Ankle System
Study Locations (11)
Other
- Turku University Hospital Finland — Turku
- Klinikverbund St. Antonius und St. Josef GmbH — Wuppertal
- Inselspital-Stiftung Universitatsspital Bern — Bern
- Spital StS AG — Thun
North Carolina
- OrthoCarolina Research Institute — Charlotte
- Duke University — Durham
California
- University California Davis — Sacramento
Michigan
- Orthopaedic Associates of Grand Rapids REI — Grand Rapids
Pennsylvania
- The Rothman Institute — Philadelphia
British Columbia
- UBC Providence Health Care Research Institute — Vancouver
Milano MI
- Humanitas San Pio X — Milan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2014-03 |
| Est. Completion | 2027-03 |
| Phase | NA |
Interested in This Trial?
Always speak with your doctor before enrolling in a clinical trial.
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02038140
The ClinicalTrials.gov registry entry for NCT02038140 describes a study currently listed as active not recruiting. It is categorized as NA, which is the standard way researchers label where a study sits along the investigational pathway from early safety work through later efficacy and post-marketing evaluation. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Zimmer Biomet, which has 102 total studies on file at ClinicalTrials.gov, and sponsors are the parties responsible for study design, oversight, and regulatory filings.
The record links to 3 conditions, with Rheumatoid Arthritis appearing as the primary indexed condition, and to 1 intervention — of which Zimmer Trabecular Metal Total Ankle System is the first listed. Interventions can include drugs, devices, procedures, behavioral programs, or observational arms, and each is tracked as a separate registry field so that downstream queries can filter accurately. When a trial lists multiple interventions, it usually reflects a multi-arm design or a comparison protocol rather than a single treatment being tested in isolation. The brief summary published in the registry is the clearest source of protocol intent and should be read before drawing conclusions from any sidebar tags.
Geographic footprint matters for practical reasons: NCT02038140 reports 11 study locations spanning 7 distinct geographic areas — top geographies include Other, North Carolina, California. A larger site network tends to correlate with broader recruitment capacity, but it does not imply anything about study quality, and site-level enrollment status can diverge from the overall registry status shown above. Every data point on this page comes from the public ClinicalTrials.gov dataset and is reproduced here for reference only; it is not a medical recommendation, an endorsement of the sponsor, or an invitation to enroll. Verify current status, eligibility criteria, and contact details directly at ClinicalTrials.gov, and discuss any participation decision with your own healthcare provider.
Frequently Asked Questions
What is clinical trial NCT02038140 about?
NCT02038140 is a clinical study titled "Zimmer Trabecular Metal Total Ankle PMCF". The primary objective of this study is to obtain implant survivorship and clinical outcome data for commercially available Zimmer Trabecular Metal Total Ankle implants used in primary or revision total ankle arthroplasty. The assessment will include implant survivorship and clinical performance meas...
What is the current status of trial NCT02038140?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 120 participants. The study started on 2014-03. Estimated completion is 2027-03.
What conditions does trial NCT02038140 study?
This clinical trial studies the following conditions: Rheumatoid Arthritis, Post Traumatic Arthritis, Degenerative Arthritis. These conditions were identified from the trial registry and reflect the primary focus areas of the research.
What interventions are being tested in trial NCT02038140?
The interventions under investigation include: Zimmer Trabecular Metal Total Ankle System (DEVICE). Each intervention is being evaluated for safety and efficacy as part of this clinical study.
Who is sponsoring clinical trial NCT02038140?
This trial is sponsored by Zimmer Biomet, which has 102 total clinical trials registered on ClinicalTrials.gov. The sponsor is responsible for the study's design, funding, and regulatory compliance.
Where is trial NCT02038140 being conducted?
This trial has 11 study locations across California, Michigan, North Carolina, Pennsylvania, British Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How Clinical Trials Work
Understand phases 1-4, trial design, randomization, and the informed consent process.
Patient Rights in Clinical Trials
Your rights as a participant: consent, withdrawal, privacy, and who to contact.
Finding the Right Clinical Trial
A practical guide to searching trials, understanding eligibility, and evaluating options.
All Guides
Browse our complete library of clinical trial educational resources.
Read our methodology — how this data is sourced, computed, and verified.